Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.

Kim MK, Jeon YK, Woo JK, Choi Y, Choi DH, Kim YH, Kim CW.

Mol Cancer. 2011 Aug 16;10:98. doi: 10.1186/1476-4598-10-98.

2.

Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

Azarova AM, Lyu YL, Lin CP, Tsai YC, Lau JY, Wang JC, Liu LF.

Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11014-9. Epub 2007 Jun 19.

3.

Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients.

Chan A, Weilbach FX, Toyka KV, Gold R.

Clin Exp Immunol. 2005 Jan;139(1):152-8.

4.

Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells.

Hövelmann S, Beckers TL, Schmidt M.

Br J Cancer. 2004 Jun 14;90(12):2370-7.

5.

Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha.

van der Heijden J, de Jong MC, Dijkmans BA, Lems WF, Oerlemans R, Kathmann I, Schalkwijk CG, Scheffer GL, Scheper RJ, Jansen G.

Ann Rheum Dis. 2004 Feb;63(2):138-43.

7.

Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry.

Ajuh P, Kuster B, Panov K, Zomerdijk JC, Mann M, Lamond AI.

EMBO J. 2000 Dec 1;19(23):6569-81.

Supplemental Content

Support Center